Show simple item record

dc.contributor.advisorGriffin, Matthew
dc.contributor.advisorO' Brien, Timothy
dc.contributor.advisorCeredig, Rhodri
dc.contributor.authorDennedy, Michael Conall
dc.description.abstractHuman monocytes are classified as classical, intermediate and non-classical according to their surface expression of CD14 and CD16. They also represent precursors to atherogenic foam cells and macrophages in metabolically adverse crown-like structures. Monocyte distribution, phenotype and function were investigated in obese individuals with and without type 2 diabetes in relation to clinical parameters of metabolic and cardiovascular risk. Peripheral monocytes obtained from obese and non-obese subjects were enumerated and their phenotype investigated using flow cytometry and q-RT-PCR. Multivariate analyses were performed against validated clinical markers of cardiovascular and metabolic risk. When compared to their non-obese counterparts, obese individuals demonstrated decreased total and classical monocyte numbers with proportionately increased intermediate monocytes and unchanged non-classical monocytes. Surface staining of intermediate monocytes for HLA-DR identified two distinct subpopulations with mid (DR mid) and high (DR hi) level expression respectively. Expansion of the intermediate subset of monocytes in obese individuals occurred specifically within the DRmid subpopulation and this correlated with key indices of lipid metabolism and glycemia. DRmid intermediate monocytes displayed higher surface expression of pro-inflammatory and lipid receptors and higher uptake of acetylated-LDL. A distinct subpopulation of intermediate monocytes sharing phenotypic features with atherogenic foam cells and macrophages in crown-like structures is expanded in the blood of obese individuals with and without type 2 diabetes. Direct interactions between modified lipoproteins and circulating monocyte subpopulations may represent an early pathogenic driver of obesity-associated atherosclerosis and adipose tissue inflammation.en_US
dc.subjectType 2 Diabetesen_US
dc.subjectLipoprotein Metabolismen_US
dc.subjectDepartment of Medicine and the Regenerative Medicine Institute (REMEDI)en_US
dc.subjectDepartment of Medicineen_US
dc.titleAn investigation of the immunometabolic interactions of obesityen_US
dc.contributor.funderHealth Research Board of Irelanden_US
dc.contributor.funderHealth Services Executiveen_US
dc.local.noteA specific type of white blood cell can contribute to heart disease by accumulating too much cholesterol. This cell circulates in higher quantities in obese individuals with and without type 2 diabetes.en_US

Files in this item

Attribution-NonCommercial-NoDerivs 3.0 Ireland
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. Please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.

The following license files are associated with this item:


This item appears in the following Collection(s)

Show simple item record